The Pharma Letter provides subscribers with daily, up-to-date news, business intelligence, comment and analysis for the Pharmaceuticals, Biotechnology and Generics sectors of the overall health care industry, backed by a team of respected writers with many years of experience in the field.
GlaxoSmithKline buys full control of Cellzome
16 May 2012
UK pharma giant GlaxoSmithKline (LSE: GSK) has signed an agreement to fully acquire privately
Latest Pharma Letter Articles
UK's NICE does U-turn, recommending Zytiga as Janssen cuts price
16 May 2012
UK drugs watch dog the National Institute for Health and Clinical Excellence (NICE) has reversed
Cornerstone makes $125 million, plus, bid for EKR Thera
16 May 2012
In a second acquisition move within a matter of months, USA-based specialty drugmaker Cornerstone
Amylin said to be attracting several Big Pharma suitors
16 May 2012
US biotech firm Amylin Pharmaceuticals (Nasdaq: AMLN), which earlier this year rebuffed a $22
Merck KGaA 1st-qtr 2012 sales rise but net profit plunges
15 May 2012
German drug major Merck KGaA (MRK: DE) this morning reported first-quarter 2012 results with
Hikma may invest $100 million in Ukrainian pharma market
15 May 2012
Hikma Pharmaceuticals (LSE: HIK), Jordan's largest pharmaceutical company which is listed on
Dr Reddy's sees FY2011/12 sales rise 30%
14 May 2012
India's second-largest drugmaker, Dr Reddy's Laboratories (NYSE: RDY) posted full year ended
News From the Web
Glenmark Generics gets US FDA tentative nod for zolmitriptan tablets
16 May 2012 | pharmabiz.com
ReNeuron signs cell manufacturing deal with Angel Biotechnology
16 May 2012 | Proactive Investors UK
5 Biotechnology Stocks With Upcoming Catalysts
16 May 2012 | Seeking Alpha
Infinity Added to NASDAQ Biotechnology Index
16 May 2012 | EON: Enhanced Online News (press release)
Octoplus publishes first quarter business update
16 May 2012 | Reuters
Evotec Becomes the First Contract Research Facility in Europe to Offer ...
16 May 2012 | MarketWatch (press release)
Simcere Pharmaceutical Group Increases Sales but Misses Revenue Estimate
16 May 2012 | DailyFinance
Aoxing Pharmaceutical Company Announces Third Quarter Fiscal 2012 Financial ...
16 May 2012 | MarketWatch (press release)
Final Glance: Biotechnology companies
15 May 2012 | CBS News
Veloxis Pharmaceuticals announces financial results for the first quarter 2012 ...
15 May 2012 | MarketWatch (press release)
Hubei Minkang Pharmaceutical Ltd. Closes Private Placement of $791189
15 May 2012 | MarketWatch (press release)
- UK's NICE does U-turn, recommending Zytiga as Janssen cuts price
- ABPI chief asks: Is saving money more important than saving lives?
- Ambitious growth targets set for Bayer Healthcare in 2014
- Ophthalmic drugs market set for $18.7 billion value in 2012, says Visiongain
- GlaxoSmithKline buys full control of Cellzome
